Advanced Diagnostic Solutions for Precision Medicine
NABL-accredited laboratory offering 93 specialized diagnostic tests across 11 clinical specialties. From prenatal genetics to infectious disease detection, we provide accurate, timely results that guide critical healthcare decisions.
Non-invasive prenatal screening and biochemical marker panels using cfDNA sequencing and immunoassay for early fetal genetic detection.
Focused non-invasive prenatal screening targeting the three most common aneuploidies: trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). Analyzes cell-free fetal DNA from maternal blood with >99% detection rate.
Comprehensive non-invasive prenatal screening covering common autosomal aneuploidies (T21, T18, T13) plus sex chromosome aneuploidies (monosomy X, XXY, XYY, XXX). Provides fetal sex determination and expanded aneuploidy detection.
Advanced non-invasive prenatal screening including all common aneuploidies plus microdeletion syndromes (22q11.2 deletion/DiGeorge, 1p36 deletion, Angelman/Prader-Willi, Cri-du-chat, Wolf-Hirschhorn). Highest resolution NIPT available.
First trimester biochemical screening measuring beta-hCG and PAPP-A combined with nuchal translucency ultrasound for Down syndrome risk assessment. Time-sensitive Dissociation-Enhanced Lanthanide Fluorescence Immunoassay for high sensitivity.
Enhanced first trimester screening combining beta-hCG and PAPP-A with placental growth factor (PlGF) for dual assessment of aneuploidy risk and preeclampsia prediction. Enables early intervention strategies for pregnancy complications.
Second trimester maternal serum screening measuring AFP, beta-hCG, and unconjugated estriol (uE3) for neural tube defects and Down syndrome risk assessment. Provides pregnancy-specific risk calculation.
Enhanced second trimester screening adding inhibin A to triple marker panel for improved Down syndrome and trisomy 18 detection rates. Comprehensive maternal serum screening with highest second trimester sensitivity.